PL1710236T3 - Pochodne pirydyny i chinoliny - Google Patents
Pochodne pirydyny i chinolinyInfo
- Publication number
- PL1710236T3 PL1710236T3 PL05708100T PL05708100T PL1710236T3 PL 1710236 T3 PL1710236 T3 PL 1710236T3 PL 05708100 T PL05708100 T PL 05708100T PL 05708100 T PL05708100 T PL 05708100T PL 1710236 T3 PL1710236 T3 PL 1710236T3
- Authority
- PL
- Poland
- Prior art keywords
- quinoline
- pyridine
- derivatives
- blocking
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200400072A ES2237332B1 (es) | 2004-01-14 | 2004-01-14 | Derivados de piridinio y quinolinio. |
EP05708100A EP1710236B1 (fr) | 2004-01-14 | 2005-01-11 | Derives de pyridine et de quinoline |
PCT/ES2005/070002 WO2005068429A1 (fr) | 2004-01-14 | 2005-01-11 | Derives de pyridine et de quinoline |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1710236T3 true PL1710236T3 (pl) | 2010-08-31 |
Family
ID=34778265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05708100T PL1710236T3 (pl) | 2004-01-14 | 2005-01-11 | Pochodne pirydyny i chinoliny |
Country Status (16)
Country | Link |
---|---|
US (1) | US7781458B2 (fr) |
EP (2) | EP1710236B1 (fr) |
JP (2) | JP5047627B2 (fr) |
KR (1) | KR101157206B1 (fr) |
CN (1) | CN1910153B (fr) |
AT (1) | ATE461918T1 (fr) |
BR (1) | BRPI0506486A (fr) |
CA (1) | CA2553328C (fr) |
DE (1) | DE602005020112D1 (fr) |
DK (1) | DK1710236T3 (fr) |
ES (2) | ES2237332B1 (fr) |
HK (1) | HK1100441A1 (fr) |
MX (1) | MXPA06007940A (fr) |
PL (1) | PL1710236T3 (fr) |
PT (1) | PT1710236E (fr) |
WO (1) | WO2005068429A1 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8586613B2 (en) * | 2004-01-14 | 2013-11-19 | Universidad De Granada | Pyridinium and quinolinium derivatives |
CA2729857A1 (fr) | 2008-07-04 | 2010-01-07 | Traslational Cancer Drugs Pharma, S.L. | Methodes pour le traitement et le diagnostic du cancer |
US20100068302A1 (en) * | 2008-09-17 | 2010-03-18 | Traslational Cancer Drugs Pharma, S.L. | Methods and compositions for the treatment of cancer |
US20110212994A1 (en) * | 2009-06-26 | 2011-09-01 | Brian Clem | Small Molecule Choline Kinase Inhibitors, Screening Assays, and Methods for Safe and Effective Treatment of Neoplastic Disorders |
WO2012041493A1 (fr) * | 2010-09-28 | 2012-04-05 | Julius-Maximilians-Universität Würzburg | Sels d'aminoquinoline, leurs procédés de production et leur utilisation en tant qu'agents actifs pour des applications biotechnologiques et médicales contre les toxines binaires |
EP2468259A1 (fr) * | 2010-12-23 | 2012-06-27 | Traslational Cancer Drugs Pharma, S.L. | Compositions pharmaceutiques de dérivés de pyridinium et de quinolinium |
JP2014527397A (ja) | 2011-06-20 | 2014-10-16 | トラスラショナル、キャンサー、ドラッグス、ファーマ、ソシエダッド、リミターダTraslational Cancer Drugs Pharma, S.L. | 癌患者の化学療法に対する臨床応答を予測する方法 |
KR20140069204A (ko) * | 2011-09-22 | 2014-06-09 | 버텍스 파마슈티칼스 인코포레이티드 | 콜린 키나제의 억제제로서 유용한 화합물 |
ES2472367B1 (es) * | 2012-12-28 | 2015-06-02 | Universidad De Granada | Inhibidores no simétricos de colina quinasa con actividad antitumoral y antimalárica |
WO2015028662A1 (fr) | 2013-08-30 | 2015-03-05 | Consejo Superior De Investigaciones Cientificas (Csic) | Compositions et méthodes de caractérisation et de traitement de la polyarthrite rhumatoïde |
ES2482290B1 (es) * | 2014-06-05 | 2015-05-19 | Universidad De Granada | Inhibidores polares simétricos de colina cinasa con actividad antitumoral |
CN109790164B (zh) | 2016-07-25 | 2022-01-25 | 内尔维亚诺医疗科学公司 | 作为胆碱激酶抑制剂的嘌呤和3-去氮杂嘌呤类似物 |
EP3652177A1 (fr) | 2017-07-11 | 2020-05-20 | Nerviano Medical Sciences S.r.l. | Dérivés de pyrazolo-quinazoline utilisés en tant qu'inhibiteurs de choline kinase |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4206215A (en) * | 1976-02-25 | 1980-06-03 | Sterling Drug Inc. | Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes |
GB1533952A (en) * | 1976-02-25 | 1978-11-29 | Sterling Drug Inc | Anti-microbial bis-pyridinium compounds |
FR2498187A1 (fr) * | 1981-01-16 | 1982-07-23 | Rhone Poulenc Sante | Procede de preparation d'amino-4 chloro-7 quinoleines |
IL89026A (en) * | 1988-01-29 | 1993-02-21 | Lilly Co Eli | Substituted quinolines and cinnolines, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them |
ES2117950B1 (es) * | 1996-08-02 | 1999-09-16 | Univ Granada | Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular. |
-
2004
- 2004-01-14 ES ES200400072A patent/ES2237332B1/es not_active Expired - Fee Related
-
2005
- 2005-01-11 DK DK05708100.2T patent/DK1710236T3/da active
- 2005-01-11 CA CA2553328A patent/CA2553328C/fr not_active Expired - Fee Related
- 2005-01-11 KR KR1020067016298A patent/KR101157206B1/ko not_active IP Right Cessation
- 2005-01-11 AT AT05708100T patent/ATE461918T1/de active
- 2005-01-11 WO PCT/ES2005/070002 patent/WO2005068429A1/fr active Application Filing
- 2005-01-11 CN CN2005800024289A patent/CN1910153B/zh not_active Expired - Fee Related
- 2005-01-11 EP EP05708100A patent/EP1710236B1/fr active Active
- 2005-01-11 EP EP09157208A patent/EP2085386A3/fr not_active Withdrawn
- 2005-01-11 PL PL05708100T patent/PL1710236T3/pl unknown
- 2005-01-11 JP JP2006548321A patent/JP5047627B2/ja not_active Expired - Fee Related
- 2005-01-11 DE DE602005020112T patent/DE602005020112D1/de active Active
- 2005-01-11 ES ES05708100T patent/ES2343418T3/es active Active
- 2005-01-11 US US10/597,095 patent/US7781458B2/en not_active Expired - Fee Related
- 2005-01-11 BR BRPI0506486-4A patent/BRPI0506486A/pt not_active IP Right Cessation
- 2005-01-11 MX MXPA06007940A patent/MXPA06007940A/es active IP Right Grant
- 2005-01-11 PT PT05708100T patent/PT1710236E/pt unknown
-
2007
- 2007-07-31 HK HK07108357.3A patent/HK1100441A1/xx not_active IP Right Cessation
-
2012
- 2012-03-19 JP JP2012062569A patent/JP5619805B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP5047627B2 (ja) | 2012-10-10 |
ES2237332A1 (es) | 2005-07-16 |
MXPA06007940A (es) | 2007-01-23 |
ES2343418T3 (es) | 2010-07-30 |
EP1710236B1 (fr) | 2010-03-24 |
WO2005068429A1 (fr) | 2005-07-28 |
JP5619805B2 (ja) | 2014-11-05 |
KR20060110364A (ko) | 2006-10-24 |
EP1710236A1 (fr) | 2006-10-11 |
EP2085386A3 (fr) | 2009-10-28 |
ATE461918T1 (de) | 2010-04-15 |
BRPI0506486A (pt) | 2007-02-13 |
JP2012149077A (ja) | 2012-08-09 |
CA2553328A1 (fr) | 2005-07-28 |
DE602005020112D1 (de) | 2010-05-06 |
CN1910153B (zh) | 2010-05-26 |
CA2553328C (fr) | 2012-05-15 |
ES2237332B1 (es) | 2006-11-01 |
EP2085386A2 (fr) | 2009-08-05 |
US20070185170A1 (en) | 2007-08-09 |
KR101157206B1 (ko) | 2012-07-06 |
JP2007517837A (ja) | 2007-07-05 |
DK1710236T3 (da) | 2010-07-12 |
HK1100441A1 (en) | 2007-09-21 |
PT1710236E (pt) | 2010-06-18 |
CN1910153A (zh) | 2007-02-07 |
US7781458B2 (en) | 2010-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1100441A1 (en) | Derivatives of pyridine and quinoline | |
UA116187C2 (uk) | ГЕТЕРОАРИЛЗАМІЩЕНІ ПІРОЛО[2,3-b]ПІРИДИНИ Й ПІРОЛО[2,3-b]ПІРИМІДИНИ ЯК ІНГІБІТОРИ ЯНУС-КІНАЗИ | |
UA95244C2 (ru) | Соединения и способ модулирования активности киназ, и показания для их применения | |
ATE447559T1 (de) | 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3- carboxamid derivate als mek inhibitoren zur behandlung von hyperproliferativen erkrankungen | |
WO2007056112A3 (fr) | 1h-imidazoquinolines substituees par hydroxy et alcoxy et procedes correspondants | |
TW200740815A (en) | P38 MAP kinase inhibitors and methods for using the same | |
EA200800396A1 (ru) | Гидроксизамещенные 1н-имидазопиридины и способы | |
BR112012016111A2 (pt) | Composto hererocíclico contendo nitrogênio, fungicida agrícola, e, produto intermediário | |
NO20090581L (no) | Hydroksylerte og metoksylerte syklopenta[D]pyrimidiner som AKT-proteinkinaseinhibitorer | |
HK1166465A1 (en) | 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position as parp inhibitors for use in treating cancer | |
WO2006113942A3 (fr) | Procede d'inhibition de l'activite de cathepsine | |
EP1740581A4 (fr) | Composes derives de pyridyle substitues aux positions 2, 4, 6 utiles comme inhibiteurs de la beta-secretase dans le traitement de la maladie d'alzheimer | |
MY148480A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
BR0318383A (pt) | derivados de pirazoloisoquinolina como inibidores de cinase | |
ATE432260T1 (de) | Pyridinderivate als pkc-theta-hemmer | |
ATE532789T1 (de) | Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren | |
WO2004080418A3 (fr) | Composes d'acide nucleique pouvant inhiber l'angiogenese et la croissance tumorale | |
ATE493418T1 (de) | Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren | |
BRPI0608216A2 (pt) | agente terapêutico para um tumor, método para tratar um tumor, e, uso de um composto de benzoìla, uma pró-groga do mesmo ou um sal farmaceuticamente aceitável do mesmo | |
DE602005017626D1 (de) | Antivirale verwendung von borinsäurekomplexen | |
EP1817311A4 (fr) | Derives pyridyle 2,3,4,6-substitues utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer | |
HK1114876A1 (en) | Arthrospira-based compositions and uses thereof | |
WO2007077203A3 (fr) | Derives de triterpenequinone et de triterpenephenol et leur application pour le traitement de tumeurs et de maladies parasitaires | |
WO2006133928A3 (fr) | Utilisation de phenylsemicarbazones pour le traitement des semences | |
WO2006118973A3 (fr) | Procedes d'utilisation de composes heterocycliques [3.2.0] et de leurs analogues |